Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1784PDF: 1413HTML: 327 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8335PDF: 5759HTML: 87205Fig.1b: 140Fig.1c: 137Fig.2a: 122Fig.2b: 130Fig.4: 149Fig.2c: 128Fig.3: 145Tab.1: 185Tab.2: 158Tab.3: 153Tab.4: 173Fig1a: 136 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3871PDF: 963HTML: 3374Untitled: 152Cneo. Fig.1: 83Untitled: 79Untitled: 97Untitled: 96 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4394PDF: 1244HTML: 1806Untitled: 145Untitled: 140 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2593PDF: 1140HTML: 2549Figure 1: 124 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2529PDF: 756HTML: 6413Untitled: 173Untitled: 141Untitled: 144Untitled: 150 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3047PDF: 1372HTML: 3955 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1560PDF: 732HTML: 10133Figures 1,2,3: 131 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2303PDF: 752HTML: 8668Efremov 1: 158Efremov 2: 136 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2558PDF: 921HTML: 5477 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
2982PDF: 2515HTML: 174 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2552PDF: 966HTML: 3216 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2067PDF: 1250HTML: 16948Bassan Fig.1: 117Bassan Fig.2: 114Bassan Fig.4: 100Fig.3: 138 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3670PDF: 1792HTML: 5110Table 1: 155 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2969PDF: 1259HTML: 2468 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4147PDF: 2523HTML: 2168 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2060PDF: 811HTML: 1916Fig 1 Rossi: 121 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1313PDF: 1054HTML: 151 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2845PDF: 773HTML: 7087Kost Fig1: 132Kost Fig 2: 124Kost Fig3: 122Kost Fig 4: 129Kost Fig5: 130Kost fig 6: 113 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1374PDF: 914HTML: 83 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
2980PDF: 852HTML: 2893 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
2910PDF: 1021HTML: 1644 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3347PDF: 790HTML: 6672 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
908PDF: 626HTML: 179 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1195PDF: 704HTML: 915 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2287PDF: 778HTML: 17405Fig1 Caligaris: 112Fig.2 Caliga: 148 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
1864PDF: 1084HTML: 3626 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2685PDF: 1343HTML: 3019Cover Letter: 159 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3482PDF: 1352HTML: 9140Untitled: 238Untitled: 130Untitled: 127Untitled: 126Untitled: 142Untitled: 284 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1392PDF: 752HTML: 587







